Document:

<PAGE>   1
                                                                    EXHIBIT 4.16

DATED December 19, 1997

INVESTOR AGREEMENT

JAFFE, RAITT, HEUER & WEISS
Suite 2400
One Woodward Avenue
Detroit
Michigan 48226
USA
<PAGE>   2
THIS Investor Agreement (this "Agreement") is made the 19th day of December
1997 between Genomic Solutions, Inc, a Delaware corporation (the "Company") and
each of the person identified below, all residents of the United Kingdom ("the
Investors").

RECITALS

A. The Investors desire to exchange (the "Transaction") the entire issued share
   capital of PBA Technology Limited for certain shares (the "Shares") of the
   Company and have entered or will enter into certain agreements in futherance
   of the Transaction.

B. The issuance (the "Issuance") of the Shares to the Investors is exempt from
   the registration requirements of the Securities Act 1933, as amended (the
   "Act").

C. To establish and preserve available exemptions for the Company under the Act,
   the Investors and the Company have agreed to the restrictions and rights set
   forth herein. The Company and the Investors are entering into this Agreement
   to set forth certain rights, covenants, representations and warranties with
   respect to the Shares.

INVESTOR COVENANTS, REPRESENTATIONS AND WARRANTIES

Each Investor covenants, represents and warrants to the Company as follows, with
the knowledge that the Company will rely on the following in issuing the Shares.
All covenants, representations and warranties shall survive indefinitely:

1. Purchase for Investment. I am purchasing the Shares solely for my own account
   for investment only and not for the account of any other person and not for
   distribution, assignment or resale to others, and no other person has a
   direct or indirect beneficial interest in the Shares.

2. Means and Knowledge of Investor. I have adequate means of providing for my
   current needs and possible personal contingencies, have no need for liquidity
   in any investment in the Company, am able to bear the substantial economic
   risks of an investment in the Company for an indefinite period of time, and
   at present time could afford a complete loss of my investment in the Company.
   I have such knowledge and experience of financial and business matters as are
   necessary in order to enable me to utilise the information made available to
   me in connection with the offering of the Shares and to make an informed
   business decision with respect to my investment in the Company.

3. Restrictions on Transfer of Stockholder Shares

(a) Lock-Up:  Upon notification from the Company that the Company intends to
    engage in an initial public offering, I agree that, without the prior
    written consent of the Company, I will not offer, sell, contract to sell of
    otherwise dispose of (or announce any offer, sale, contract of sale of other
    disposition), directly or indirectly, any of the

                                       1
<PAGE>   3

       Shares, of any securities convertible into or exchangeable for the
       Shares, until the date six (6) months after the effective date of the
       initial public offering of the Shares, to the extent required by an
       underwriter in connection with the initial public offering.

   (b) Restrictions under Securities Act of 1933.  In addition to the
       restrictions imposed by Section 3(a), I recognize that the stock
       certificates representing the Shares will contain the following legend,
       and I hereby covenant to act in accordance with the following legend:

       THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
       1933, AS AMENDED (THE "ACT").  THE SHARES MAY NOT BE SOLD, OFFERED FOR
       SALE, PLEDGED OR HYPOTHECATED OR OTHERWISE TRANSFERRED TO ANY RESIDENT OF
       THE UNITED STATES FOR A PERIOD OF TWELVE MONTHS IN THE ABSENCE OF AN
       EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER THE ACT AND
       APPLICABLE STATE SECURITIES LAWS OR UNLESS AN OPINION OF COUNSEL
       ACCEPTABLE TO THE COMPANY HAS BEEN OBTAINED TO THE EFFECT THAT THE
       PROPOSED TRANSFER COMPLIES WITH REGULATION S UNDER THE ACT OR OTHER
       EXEMPTION FROM REGISTRATION UNDER THE ACT AND WITH APPLICABLE STATE
       SECURITIES LAWS.

INVESTOR RIGHTS

4.  Registration Rights

   (a) Piggy-Back Registration Rights.  Subject to Section 4(b) below if the
       Company proposes to register any of its stock or other securities under
       the Securities Act of 1933, as amended, in connection with the public
       offering of such securities solely for cash (other than a registration
       relating solely to the sale of securities to participants in a Company
       stock plan, or a registration on any form which does not include
       substantially the same information as would be required to be included in
       a registration statement covering the sale of the Shares or a SEC Rule
       145 Transaction, the Company shall give prompt written notice to the
       Investors of its intention to effect such a registration (each a
       "Piggyback Notice"), including without limitation any initial public
       offering and any subsequent offering whether or not pursuant to any
       exercise of any shareholder demand registration rights, and, provided
       that the Company has received a written request for inclusion therein
       within fifteen (15) days after the date of sending of such notice, the
       Company shall include in such registration, registration of all Shares.
       The Company shall pay all expenses incident to the Company's performance
       of or compliance with this section, other than underwriters' discount and
       commissions, which are the sole responsibility of the Investors, but
       including, without limitation, all registration and filing fees, fees and
       expenses of compliance with securities or blue sky laws, printing
       expenses, messenger and delivery expenses, and fees and disbursements of
       counsel for the Company and

                                       2
<PAGE>   4
          all independent certified public accountants and underwriters.
          Notwithstanding the foregoing, after the Company's initial public
          offering, the Company will not be required to include the Shares in
          the offering or to give notice to the Investors if the underwriters
          have advised the Company in writing that in their judgment market
          conditions will not allow the inclusion of any shares for resale in
          such offering.

     (b)  Limitations on Registration Rights.  The registration rights of the
          Investors granted pursuant to Section 4(a) above are subject to the
          rights of the holders of the Company's Series M Preferred Stock,
          Series B Preferred Stock and Series C Preferred Stock (the "Preferred
          Stock"), as more particularly described in that certain Shareholders
          Agreement among the Company and the holders of the Company's capital
          stock.  The Company shall be required to include the Shares in any
          registration only to the extent that such inclusion will not reduce
          the amount of shares of Preferred Stock included in the registration.
          Thereafter, to the extent that the total amount of Shares requested by
          the Investors to be included in such offering exceeds the amount of
          securities sold other than by the Company that the underwriters
          determine may be included in the offering, the Shares to be included
          will be apportioned pro rata among the Investors according to the
          total amount of securities owned by each Investor or in such other
          proportions as shall mutually be agreed to by such investors.

     (c)  Indemnification.  In the event any of the Shares are included in a
          registration statement under this Section:

         (i)   To the extent permitted by law, the Company will indemnify and
               hold harmless each Investor, and underwriter (as defined in the
               Securities Act of 1933) for such Investor and each person, if
               any, who controls such Investor or underwriter within the meaning
               of the Act or the Securities Exchange Act of 1934, as amended
               (the "1934 Act"), against any losses, claims, damages, or
               liabilities (joint or several) to which they may become subject
               under the Act, or the 1934 Act or other federal or state laws,
               insofar as such losses, claims, damages, or liabilities (or
               actions in respect thereof) arise out of or are based upon any of
               the following statements, omissions or violations (collectively a
               "Violation"): (x) any untrue statement or alleged untrue
               statement of a material fact contained in such registration
               statement, including any preliminary prospectus or final
               prospectus contained therein or any amendments or supplements
               thereto; (y) the omission or alleged omission to state therein a
               material fact required to be stated therein, or necessary to make
               the statements therein not misleading; or (z) any violation or
               alleged violation by the Company of the Act, the 1934 Act, any
               state securities law or any rule or regulation promulgated under
               the Act, or the 1934 Act or any state securities laws; and the
               Company will pay to each such Investor, underwriter of
               controlling person, as incurred, any legal or other expenses
               reasonably incurred by one law firm retained by them (or such
               additional law firms retained by an Investor or Investors if such
               Investor or Investors reasonably believe there exists a conflict
               of interest among them) in connection with investigating or
               defending any such loss,

                                       3
<PAGE>   5

              claim, damage, liability or action; provided, however, that the
              indemnity agreement contained in this subsection shall not apply
              to amounts paid in settlement of any such loss, claim, damage,
              lability or action if such settlement is effected without the
              consent of the Company (which consent shall not be unreasonably
              withheld), nor shall the Company be liable in any such case for
              any loss, claim, damage, liability or action to the extent that it
              arises out of or is based upon a Violation which occurs in
              reliance upon and in conformity with written information furnished
              expressly for use in connection with such registration by any such
              Investor, underwriter or controlling person.

              (ii)   To the extent permitted by law, each selling Investor will
                     indemnify and hold harmless the Company, each of its
                     directors each of its officers who has signed the
                     registration statement, each person, if any, who controls
                     the Company within the meaning of the Act, any underwriter,
                     any other Investor selling securities in such registration
                     statement and any controlling person of any such
                     underwriter or other Investor, against any losses, claims,
                     damages or liabilities (joint or several) to which any of
                     the foregoing persons may become subject, under the Act, or
                     the 1934 Act or other federal or state law, insofar as such
                     losses, claims, damages or liabilities (or actions in
                     respect thereto) arise out of or are based upon any
                     Violation, in each case to the extent (and only to the
                     extent) that such Violation occurs in reliance upon and in
                     conformity with written information furnished by such
                     Investor expressly for use in connection with such
                     registration; and each such Investor will pay, as incurred,
                     any legal or other expenses reasonably incurred by any
                     person intended to be indemnified pursuant to this
                     subsection, in connection with investigating or defending
                     any such loss, claim, damage, liability or action [delete;]
                     if such settlement is effected without the consent of the
                     Investor, which consent shall not be unreasonably withheld;
                     provided that, in no event shall any indemnity under this
                     subsection exceed the net proceeds from the offering
                     received by such Investor.

              (iii)  Promptly after receipt by an indemnified party under this
                     Section of notice of the commencement of any action
                     (including any governmental action), such indemnified party
                     will, if a claim in respect thereof is to be made against
                     any indemnifying party under this Section, deliver to the
                     indemnifying party a written notice of the commencement
                     thereof and the indemnifying party shall have the right to
                     participate in, and, to the extent the indemnifying party
                     so desires, jointly with any other indemnifying party
                     similarly noticed, to assume the defense thereof with
                     counsel mutually satisfactory to the parties; provided,
                     however, that an indemnified party (together with all other
                     indemnified parties which may be represented without
                     conflict by one counsel) shall have the right to retain one
                     separate counsel, with the fees and expenses to be paid by
                     the indemnifying party,

                                       4
<PAGE>   6

                if representation of such indemnified party by the counsel
                retained by the indemnifying party would be inappropriate due to
                actual or potential differing interests between such indemnified
                party and any other party represented by such counsel in such
                proceeding. The failure to deliver written notice to the
                indemnifying party within a reasonable time of the commencement
                of any such action, if prejudicial to its ability to defend such
                action, shall relieve such indemnifying party of any liability
                to the indemnified party under this Section, but the failure to
                deliver written notice to the indemnifying party will not
                relieve it of any liability that it may have to any indemnified
                party otherwise than under this Section.

       (iv)     The obligations of the Company and Investors under this Section
                shall survive the completion of any offering of securities in a
                registration statement under this Section, and otherwise.

5.   Tag-Along Rights.  If a third-party ("Intended Transferee") presents a
     bona fide written offer (the "Offer") to purchase fifty percent (50%) or
     more the Company's Subject Common Stock from any holder or holders of the
     Company's common stock other than the Investors (the shares to be purchased
     are referred to herein as the "Subject Shares"), and if the holder of the
     Subject Shares (the "Intended Transferor") desires to accept the Offer, the
     Investors shall be entitled to participate in the transaction with the
     Intended Transferee, in the same capacity as the Intended Transferor, such
     that each of the Investors shall be entitled to transfer, on the terms and
     conditions and in the manner set forth in the Offer, that percentage of his
     or her Shares equal to the percentage of the Subject Common Stock that the
     Subject Shares represent.  "Subject Common Stock" means all common stock of
     the Company including all stock that have been or may be converted into
     common stock of the Company. In order to exercise his or her rights under
     the Section, an Investor shall so notify the Intended Transferor, the
     Intended Transferee and the Board of Directors of the Company on or before
     the twentieth (20th) business day after the Offer is received by the
     Intended Transferees. NOTWITHSTANDING ANY PROVISION IN THIS AGREEMENT TO
     THE CONTRARY, THE PROVISIONS OF THIS SECTION 5 SHALL ONLY BE BINDING UPON
     AND ENFORCEABLE AGAINST HOLDERS OF THE COMPANY'S COMMON STOCK WHO HAVE DULY
     APPROVED THIS INVESTORS AGREEMENT AND SECTION 5 HEREOF BY THE REQUISITE
     VOTE, CONSENT OR AGREEMENT.

MISCELLANEOUS

6.   Notices.  Any and all notices, requests, demands and other communications
     permitted or required hereunder shall be in writing and shall be deemed
     given, on receipt if personally delivered or sent by facsimile or other
     electronic means, or three (3) business days after mailing if mailed,
     postage prepaid, certified or registered, return receipt requested, to the
     parties at the addresses indicated below, or at such other addresses as
     they may indicate by written notice given as herein provided.

                                       5
<PAGE>   7
7.  Headings. The headings contained in this Agreement are for reference
    purposes only and shall not in any way affect the meaning or interpretation
    of this Agreement.

8.  Governing Law. This Agreement has been executed in, and shall be construed
    and enforced in accordance with the laws of the State of Delaware, United
    States of America (excluding choice of law rules of such jurisdiction).

9.  Entire Agreement. This is and shall be deemed to be the complete and final
    expression of the agreement between the parties as to the matters herein
    contained.

10. Amendments. This Agreement may only be amended by written agreement executed
    by the parties hereto.

11. Counterparts. This Agreement may be executed in two or more counterparts,
    each of which shall be deemed an original and all of which together shall be
    considered one and the same agreement.

12. Photographic Copies. Photographic or facsimile reproductions of this
    Agreement may be made and relied upon the same extent as though the copy
    were an original.

    THE PARTIES IDENTIFIED BELOW have executed this Agreement as of the date
    first written above

GENOMIC SOLUTIONS, INC     )

by

Signature page to Investor Agreement, dated December 19, 1997
between Genomic Solutions Inc. and the Investors

                                              Genomic Solutions Inc., a Delaware
                                              corporation

                                              By: /s/ Jeffrey S. Williams
                                                 -------------------------------
                                                  Jeffrey S. Williams

                                              Its: President, Chief Executive
                                              Officer and Chairman of the Board
<PAGE>   8
SAM C. WHITBREAD
Southill Park,
Biggleswade, Beds,
SG19 9LL
United Kingdom          Sam C. Whitbread
                       ---------------------)

DR. JANE STEVENS
3 Clarendon Street,
Cambridge, CB1 1JU
United Kingdom         ---------------------)

SIMON COOKE
Deers,
Clavering,
Essex, CB11 4PX
United Kingdom         ---------------------)

MARTIN BLOOM
50 Eton Court,
Eton Avenue,
London,
NW3 3HJ
United Kingdom         ---------------------)

MALCLOM BOSTON
13 Trumpington Road,
Cambridge, CB2 2AJ
United Kingdom         ---------------------)

SAM C. WHITBREAD
Southill Park,
Biggleswade, Beds,
SG19 9LL
United Kingdom
                       ---------------------)

DR. JANE STEVENS
3 Clarendon Street,
Cambridge, CB1 1JU      Dr. Jane Stevens
United Kingdom         ---------------------)

SIMON COOKE
Deers,
Clavering,
Essex, CB11 4PX
United Kingdom         ---------------------)

MARTIN BLOOM
50 Eton Court,
Eton Avenue,
London,
NW3 3HJ
United Kingdom         ---------------------)

MALCOLM BOSTON
13 Trumpington Road,
Cambridge, CB2 2AJ
United Kingdom         ---------------------)

SAM C. WHITBREAD
Southill Park,
Biggleswade, Beds,
SG19 9LL
United Kingdom
                       ---------------------)

DR. JANE STEVENS
3 Clarendon Street,
Cambridge, CB1 1JU
United Kingdom         ---------------------)

SIMON COOKE
Deers,
Clavering,
Essex, CB11 4PX
United Kingdom         ---------------------)

MARTIN BLOOM
50 Eton Court,
Eton Avenue,
London,
NW3 3HJ
United Kingdom         ---------------------)

MALCOLM BOSTON
13 Trumpington Road,
Cambridge, CB2 2AJ
United Kingdom         ---------------------)

SAM C. WHITBREAD
Southill Park,
Biggleswade, Beds,
SG19 9LL
United Kingdom
                       ---------------------)

DR. JANE STEVENS
3 Clarendon Street,
Cambridge, CB1 1JU
United Kingdom         ---------------------)

SIMON COOKE
Deers,
Clavering,
Essex, CB11 4PX
United Kingdom         ---------------------)

MARTIN BLOOM
50 Eton Court,
Eton Avenue,
London,
NW3 3HJ                 Martin Bloom
United Kingdom         ---------------------)

MALCOLM BOSTON
13 Trumpington Road,
Cambridge, CB2 2AJ
United Kingdom         ---------------------)

SAM C. WHITBREAD
Southill Park,
Biggleswade, Beds,
SG19 9LL
United Kingdom
                       ---------------------)

DR. JANE STEVENS
3 Clarendon Street,
Cambridge, CB1 1JU      Dr. Jane Stevens
United Kingdom         ---------------------)

SIMON COOKE
Deers,
Clavering,
Essex, CB11 4PX
United Kingdom         ---------------------)

MARTIN BLOOM
50 Eton Court,
Eton Avenue,
London,
NW3 3HJ
United Kingdom         ---------------------)

MALCOLM BOSTON
13 Trumpington Road,
Cambridge, CB2 2AJ      Malcolm Boston
United Kingdom         ---------------------)

                                       7
<PAGE>   9
          3.   Entire Agreement.  This is and shall be deemed to be the
          complete and final expression of the agreement between the parties as
          to the matters herein contained.

          4.   Amendment.  This Agreement may only be amended by written
          agreement executed by the parties hereto.

          5.   Counterparts.  This Agreement may be executed in two or more
          counterparts, each of which shall be deemed an original and all of
          which together shall be considered one and the same agreement.

          6.   Photographic Copies.  Photographic or facsimile reproductions of
          this Agreement may be made and relied upon to the same extent as
          though the copy were an original.

               THE PARTIES IDENTIFIED BELOW have executed this Agreement as of
          the data first written above.

                                                   /s/ Suzanne C. Boston
                                                  -------------------------
                                                       Suzanne C. Boston
<PAGE>   10
ANTHONY GARY BIDDLE
55 Upper Tilehurst Street,
Hitchin,
Herts, SG5 2EF
United Kingdom                Anthony Gary Biddle
                             -----------------------)

IAN BOSTON
Oak Cottage,
High Street,
Fen Drayton,
Cambs, CB4 5SJ
United Kingdom               -----------------------)

SUZANNE CATHRYN BOSTON
73 Disraeli Road,
Putney, London
SW15 2DR
United Kingdom               -----------------------)

HELEN S MORRIS
c/o Les Teres Cottage,
Havellet,
St Peter Port,
Guernsey GY1 1AZ
Channel Isles                -----------------------) by her attorney

LUCY A MORRIS
c/o Les Teres Cottage,
Havellet,
St Peter Port,
Guernsey GY1 1AZ
Channel Islands              -----------------------) by her attorney

ANTHONY GARY BIDDLE
55 Upper Tilehurst Street,
Hitchin,
Herts, SG5 2EF
United Kingdom
                             -----------------------)

IAN BOSTON
Oak Cottage,
High Street,
Fen Drayton,
Cambs, CB4 5SJ                Ian Boston
United Kingdom               -----------------------)

SUZANNE CATHRYN BOSTON
73 Disraeli Road,
Putney, London
SW15 2DR
United Kingdom               -----------------------)

HELEN S MORRIS
c/o Les Teres Cottage,
Havellet,
St Peter Port,
Guernsey GY1 1AZ
Channel Isles                -----------------------) by her attorney

LUCY A MORRIS
c/o Les Teres Cottage,
Havellet,
St Peter Port,
Guernsey GY1 1AZ
Channel Islands              -----------------------) by her attorney

ANTHONY GARY BIDDLE
55 Upper Tilehurst Street,
Hitchin,
Herts, SG5 2EF
United Kingdom
                             -----------------------)

IAN BOSTON
Oak Cottage,
High Street,
Fen Drayton,
Cambs, CB4 5SJ
United Kingdom               -----------------------)

SUZANNE CATHRYN BOSTON
73 Disraeli Road,
Putney, London
SW15 2DR
United Kingdom               -----------------------)

HELEN S MORRIS
c/o Les Teres Cottage,
Havellet,
St Peter Port,
Guernsey GY1 1AZ              Kevin O'Donovan
Channel Isles                -----------------------) by her attorney

LUCY A MORRIS
c/o Les Teres Cottage,
Havellet,
St Peter Port,
Guernsey GY1 1AZ              Kevin O'Donovan
Channel Islands              -----------------------) by her attorney

ANTHONY GARY BIDDLE
55 Upper Tilehurst Street,
Hitchin,
Herts, SG5 2EF
United Kingdom
                             -----------------------)

IAN BOSTON
Oak Cottage,
High Street,
Fen Drayton,
Cambs, CB4 5SJ
United Kingdom               -----------------------)

SUZANNE CATHRYN BOSTON
73 Disraeli Road,
Putney, London
SW15 2DR
United Kingdom               -----------------------)

HELEN S MORRIS
c/o Les Teres Cottage,
Havellet,
St Peter Port,
Guernsey GY1 1AZ              Kevin O'Donovan
Channel Isles                -----------------------) by her attorney

LUCY A MORRIS
c/o Les Teres Cottage,
Havellet,
St Peter Port,
Guernsey GY1 1AZ              Kevin O'Donovan
Channel Islands              -----------------------) by her attorney

                                       8
<PAGE>   11

DAVID WILLIAM BYATT
26 The Paddock,
Eaton Ford,
St. Neots,
Cambs, PE19 5SA
United Kingdom              DAVID WILLIAM BYATT
                            -------------------)

JACQUELINE BYATT
26 The Paddock,
Eaton Ford,
St. Neots,
Cambs, PE19 5SA
United Kingdom
                            -------------------)

ARTHUR JOHN PINKNEY
7 Burnt Close, St. Neots,
Huntingdon,
Cambs, PE19 2LZ
United Kingdom
                            -------------------)

PAUL NICHOLAS KING
The Homestead,
Church Road,
Glatton,
Huntingdon,
Cambs, PE19 5RR
United Kingdom
                            -------------------)

DAVID WILLIAM BYATT
26 The Paddock,
Eaton Ford,
St. Neots,
Cambs, PE19 5SA
United Kingdom
                            -------------------)

JACQUELINE BYATT
26 The Paddock,
Eaton Ford,
St. Neots,
Cambs, PE19 5SA
United Kingdom             JACQUELINE BYATT
                           --------------------)

ARTHUR JOHN PINKNEY
7 Burnt Close, St. Neots,
Huntingdon,
Cambs, PE19 2LZ
United Kingdom

                          ---------------------)

PAUL NICHOLAS KING
The Homestead,
Church Road,
Glatton,
Huntingdon,
Cambs, PE19 5RR
United Kingdom
                          ---------------------)

DAVID WILLIAM BYATT
26 The Paddock,
Eaton Ford,
St. Neots,
Cambs, PE19 5SA
United Kingdom
                          ---------------------)

JACQUELINE BYATT
26 The Paddock,
Eaton Ford,
St. Neots,
Cambs, PE19 5SA
United Kingdom
                          ---------------------)

ARTHUR JOHN PINKNEY
7 Burnt Close, St. Neots,
Huntingdon,
Cambs, PE19 2LZ
United Kingdom           ARTHUR JOHN PINKNEY
                         ---------------------)

PAUL NICHOLAS KING
The Homestead,
Church Road,
Glatton,
Huntingdon,
Cambs, PE19 5RR
United Kingdom
                         ---------------------)

DAVID WILLIAM BYATT
26 The Paddock,
Eaton Ford,
St. Neots,
Cambs, PE19 5SA
United Kingdom
                            -------------------)

JACQUELINE BYATT
26 The Paddock,
Eaton Ford,
St. Neots,
Cambs, PE19 5SA
United Kingdom
                            -------------------)

ARTHUR JOHN PINKNEY
7 Burnt Close, St. Neots,
Huntingdon,
Cambs, PE19 2LZ
United Kingdom
                            -------------------)

PAUL NICHOLAS KING
The Homestead,
Church Road,
Glatton,
Huntingdon,
Cambs, PE19 5RR
United Kingdom              PAUL NICHOLAS KING
                            ------------------)

                                       9<PAGE>   1
                                                                    EXHIBIT 4.17

                    CERTIFICATE OF DESIGNATIONS, PREFERENCES
                     AND RIGHTS OF SERIES P PREFERRED STOCK

                                       OF

                             GENOMIC SOLUTIONS INC.

                                      * * *

--------------------------------------------------------------------------------
a corporation organized and existing under the General Corporation Law of the
State of Delaware,

     DOES HEREBY CERTIFY:

     That, pursuant to authority conferred upon the Board of Directors by the
Amended and Restated Certificate of Incorporation of said corporation, and
pursuant to the provisions of Section 151 of Title 8 of the Delaware Code of
1953, said Board of Directors by the unanimous written consent of its members,
filed with the minutes of the Board, adopted a resolution providing for the
designations, preferences and relative, participating, optional or other rights,
and the qualifications, limitations or restrictions thereof, of the Series P
preferred stock, which resolution is as follows:

              AUTHORIZATION AND DESIGNATION OF SERIES P PREFERRED STOCK

              WHEREAS, the Board has determined that it would be in the best
              interests of the Corporation to create a new series of preferred
              stock to be designated as "Series P Preferred Stock"; and

              WHEREAS, the Board has the authority pursuant to the Amended and
              Restated Certificate of Incorporation (the "Certificate") to
              create a new series of preferred stock and establish the rights
              and preferences of such series;

              WHEREAS, the Board has been presented with a draft of a
              Certificate of Designations, Preferences and Rights of Series P
              Preferred Stock (the

<PAGE>   2

              "Designation") which sets forth the rights and preferences of the
              Series P Preferred Stock; and

              WHEREAS, the rights and preferences of the Series P Preferred as
              set forth in the Designation generally are pari passu with the
              Series B Preferred Stock, the Series C Preferred Stock and the
              Series D Preferred Stock;

              WHEREAS, the Board has determined that it would be in the best
              interests of the Corporation and its shareholders for the
              Corporation to authorize and designate 5,000,000 shares of
              preferred stock as Series P Preferred Stock and to file the
              Designation with the Secretary of State of the State of Delaware
              all as finally completed in accordance with these resolutions.

              RESOLVED, that pursuant to the authority vested in the Board in
              accordance with the provisions of the Certificate, a series of
              Preferred Stock of the Corporation be and hereby is created, such
              series of Preferred Stock to be designated as Series P Preferred
              Stock, to consist of 5,000,000 shares of the par value of $0.001
              each of which the relative, participating, optional or other
              special rights and the qualifications, limitations or restrictions
              thereof, shall be as set forth in the Rights And Preferences And
              Restrictions Of Series P Preferred Stock Of Genomic Solutions
              Inc., attached as Exhibit A hereto.

              RESOLVED FURTHER, that the Board is authorized, empowered and
              directed to file, for and on behalf of the Corporation, the
              Designation of the Series P Preferred Stock which has the effect
              of amending the Certificate, and to prepare, finalize, modify,
              execute, deliver, amend and, if necessary, file with the
              appropriate authorities any and all related documents, instruments
              and papers, all on such terms and conditions as they, or any of
              them, deem appropriate in their sole discretion.

              RESOLVED, FURTHER, that the officers of the Corporation (the
              "Officers"), or any of them acting alone, are authorized,
              empowered and directed, for and on behalf of the Corporation, to
              execute and file with the appropriate authorities the Designation
              and any and all related documents, instruments and papers, all on
              such terms and conditions that are consistent with the Designation
              as they, or any of them, deem appropriate in their sole
              discretion.

<PAGE>   3

         IN WITNESS WHEREOF, Genomic Solutions Inc., a Delaware corporation has
caused this Certificate to be signed by Jeffrey S. Williams, its President and
Chief Executive Officer, * this 24th day of January, 2000.

                                            /s/ Jeffrey S. Williams
                                           -------------------------------------

                                      By:  Jeffrey S. Williams*
                                      Its: President and Chief Executive Officer

* Any authorized officer or the Chairman or Vice-Chairman of the Board of
Directors may execute this certificate.

<PAGE>   4

                                    EXHIBIT A

                     RIGHTS AND PREFERENCES AND RESTRICTIONS
              OF SERIES P PREFERRED STOCK OF GENOMIC SOLUTIONS INC.

Rights, Preferences and Restrictions of Series P Preferred Stock. Five Million
Shares (5,000,000) of the preferred stock authorized by the Amended and Restated
Certificate of Incorporation shall be designated as "Series P Preferred Stock".
The rights, preferences, privileges and restrictions granted to and imposed on
the Series P Preferred Stock are set forth below.

         1. Dividend Provisions. The holders of shares of Series P Preferred
Stock shall not be entitled to receive any dividends.

         2. No Liquidation Preference.

            a.    In the event of any liquidation, dissolution or winding up of
         this corporation, either voluntary or involuntary, the holders of
         shares of Series B Preferred Stock, Series C Preferred Stock, Series D
         Preferred Stock and Series M Preferred Stock shall be entitled to
         receive, prior and in preference to any distribution of any of the
         assets of this corporation available for distribution to the
         stockholders, to the holders of shares of Common Stock, Series P
         Preferred Stock or any other class of capital stock ranking junior to
         the Series B Preferred Stock, Series C Preferred Stock, Series D
         Preferred Stock or Series M Preferred Stock by reason of their
         ownership thereof, the preferential amount per share each such holder
         is entitled to receive in accordance with the Amended and Restated
         Certificate of Incorporation.

            b.    After the completion of the distribution required by
         subparagraph (a) of this Section 2 and any other distribution which may
         be required with respect to series of Preferred Stock which may from
         time to time come into existence, the assets of this corporation
         available for distribution to stockholders shall be distributed among
         the holders of shares of Common Stock and Series P Preferred Stock pro
         rata based on the number of shares of Common Stock held by each and the
         number of shares of Common Stock into which the shares of Series P
         Preferred Stock held by each may then be converted.

            c.    The Corporation shall mail written notice of any liquidation,
         dissolution or winding down not less than thirty days prior to the
         payment date stated therein to each record holder of shares of
         Preferred Stock. Any (i) acquisition of the corporation by means of
         merger or other form of corporate reorganization in which outstanding
         shares of the corporation are exchanged for securities or other
         consideration issued by the acquiring corporation or its subsidiary
         (other than a mere reincorporation transaction), (ii) sale, conveyance
         or disposition of all or substantially all of the assets of this
         corporation or (iii) transaction or series of related transactions
         effected by the corporation in which more than 50% of the voting power
         of the corporation is disposed of (other than a Public Offering as
         defined herein) (clauses (i), (ii) and (iii) are referred to herein as
         a "Sale of the

<PAGE>   5

         Corporation"), shall be deemed to be a liquidation, dissolution or
         winding up within the meaning of this Section 2.

         3.       Conversion. The holders of the Series P Preferred Stock shall
have conversion rights as follows (the "Conversion Rights"):

                  a.       Right to Convert.

                           (i) Each share of Series P Preferred Stock shall be
                  convertible, at the option of the holder thereof, at any time
                  after the date of issuance of such share, at the office of
                  this corporation or any transfer agent for the Series P
                  Preferred Stock, into such number of fully paid and
                  nonassessable shares of Common Stock as determined by dividing
                  the Original Series P Issue Price (defined below) by the
                  Conversion Price (defined below) at the time in effect for
                  such share. The Original Series P Issue Price shall be equal
                  to the quotient obtained by dividing (a) by (b), where (a) is
                  an amount equal to the sum of (x) the number of shares of
                  Series P Preferred Stock issued on the Closing Date (as such
                  term is defined in the Investment Agreement dated December 14,
                  1999, by and between the Corporation and PerkinElmer, Inc., a
                  Massachusetts corporation ("PerkinElmer")) at a purchase price
                  of six dollars and thirty cents ($6.30) multiplied by six
                  dollars and thirty cents ($6.30) and (y) the number of shares
                  of Series P Preferred Stock issued on the Closing Date at a
                  purchase price of six dollars and seventy five cents ($6.75)
                  multiplied by six dollars and seventy five cents ($6.75), and
                  (b) is the aggregate number of shares of Series P Preferred
                  Stock issued on the Closing Date. The initial Conversion Price
                  per share for shares of Series P Preferred Stock shall be
                  equal to the Original Series P Issue Price. The Conversion
                  Price for the Series P Preferred Stock shall be subject to
                  adjustment as set forth in Section 3.c. and Section 3.d.

                           (ii) Each share of Series P Preferred Stock shall
                  automatically be converted into shares of Common Stock at the
                  applicable Conversion Price at the time in effect for such
                  Series P Preferred Stock (1) immediately concurrent with the
                  consummation of the corporation's sale of its Common Stock in
                  a firm commitment underwriting led by a nationally recognized
                  underwriter pursuant to a registration statement on Form S-1
                  or its then equivalent, filed under the Securities Act of
                  1933, as amended, and resulting in an aggregate offering price
                  to the public of at least $20,000,000 and the listing of the
                  securities offered on the New York Stock Exchange or the
                  National Market Tier of the NASDAQ Stock Market (the "Public
                  Offering"), (2) immediately prior to the closing of a Sale of
                  the Corporation, so long as the consent set forth in Section
                  4.b. hereof shall have been obtained prior to such conversion,
                  and (3) on the Termination Date, as such term is defined in
                  the Securities Purchase Agreements dated December 14, 1999
                  (the "Securities Purchase Agreements"), by and between the
                  Corporation, PerkinElmer and various holders of the
                  Corporation's securities.

<PAGE>   6

                  b.       Mechanics of Conversion. Any holder of shares of
         Series P Preferred Stock shall be entitled to convert the same into
         shares of Common Stock, by surrendering the certificate or certificates
         therefor, duly endorsed, at the office of this corporation or of any
         transfer agent for the Series P Preferred Stock and by giving written
         notice by mail, postage prepaid, to this corporation at its principal
         corporate office, of the election to convert the same and stating
         therein the name or names in which the certificate or certificates for
         shares of Common Stock are to be issued. This corporation shall, as
         soon as practicable thereafter, issue and deliver at such office to
         such holder of shares of Series P Preferred Stock or to a nominee or
         nominees of such holder, a certificate or certificates for the number
         of shares of Common Stock to which such holder shall be entitled as
         aforesaid. Such conversion shall be deemed to have been made
         immediately prior to the close of business on the date of such
         surrender of the shares of Series P Preferred Stock to be converted,
         and the person or persons entitled to receive the shares of Common
         Stock issuable upon such conversion shall be treated for all purposes
         as the record holder or holders of such shares of Common Stock as of
         such date. If the conversion is in connection with an underwritten
         offering of securities registered pursuant to the Securities Act of
         1933, as amended, other than in a Public Offering as set forth in
         Section 3.a.(ii) above, the conversion may, at the option of any holder
         tendering Series P Preferred Stock for conversion, be conditioned upon
         the closing with the underwriter of the sale of securities pursuant to
         such offering, in which event the person(s) entitled to receive the
         Common Stock issuable upon such conversion of the Series P Preferred
         Stock shall not be deemed to have converted such stock until
         immediately prior to the closing of such sale of securities.

                  c.       Conversion Price Adjustments of Preferred Stock Upon
         Reorganization or Recapitalization. If at any time or from time to time
         there shall be any capital reorganization or recapitalization of the
         Common Stock (including, without limitation, any stock split or stock
         dividend), provision shall be made so that the holders of shares of
         Series P Preferred Stock shall thereafter be entitled to receive upon
         conversion of the Series P Preferred Stock, as applicable, the number
         of shares of stock or other securities or property of the corporation
         or otherwise, to which a holder of Common Stock deliverable upon
         conversion would have been entitled on such recapitalization. In any
         such case, appropriate adjustment shall be made in the application of
         the provisions of this Section 3 with respect to the rights of the
         holders of the Series P Preferred Stock after the recapitalization to
         the end that the provisions of this Section 3 (including adjustment of
         the Conversion Price then in effect and the number of shares which
         would be received upon conversion of the Series P Preferred Stock)
         shall be applicable after that event as nearly equivalent as may be
         practicable. The provisions of this clause shall similarly apply to
         successive reorganizations and reclassifications.

                  d.       Conversion Price Adjustment Upon Sale of Securities.
         Each Conversion Price shall be subject to adjustment from time to time
         as follows:

<PAGE>   7

                  (i)      If the corporation shall at any time or from time
         to time issue any shares of Common Stock, or securities convertible
         into or exercisable for Common Stock (including any shares of Common
         Stock deemed to have been issued pursuant to subdivision (iv)(c) below)
         other than Excluded Stock (as defined in clause (v) below) without
         consideration or for a consideration per share less than the Conversion
         Price for the Series P Preferred Stock in effect immediately prior to
         the issuance of such Common Stock, then any Conversion Price for the
         Series P Preferred Stock that is greater than the consideration per
         share of Common Stock or its equivalent received in such issuance or
         sale shall forthwith be lowered to be equal to the quotient obtained by
         dividing:

                           (a) an amount equal to the sum of (x) the total
                  number of shares of Common Stock outstanding (including any
                  shares of Common Stock deemed to have been issued pursuant to
                  subdivision (iv)(c) below) immediately prior to such issuance,
                  multiplied by the applicable Conversion Price for the Series P
                  Preferred Stock in effect immediately prior to such issuance,
                  and (y) the consideration received by the corporation upon
                  such issuance; by

                           (b) the total number of shares of Common Stock
                  outstanding (including any shares of Common Stock deemed to
                  have been issued pursuant to subdivision (iv)(c) below)
                  immediately after the issuance of such Common Stock.

         For the purposes of any adjustment of any Conversion Price for the
         Series P Preferred Stock pursuant to this clause, the following
         provisions shall be applicable:

                  (ii) In the case of the issuance of Common Stock for cash, the
         consideration shall be deemed to be the amount of cash paid therefor
         after deducting therefrom any discounts, commissions or other expenses
         allowed, paid or incurred by the corporation for any underwriting or
         otherwise in connection with the issuance and sale thereof.

                  (iii) In the case of the issuance of Common Stock for a
         consideration in whole or in part other than cash, the consideration
         other than cash shall be deemed to be the fair market value thereof as
         determined in good faith by the corporation's Board of Directors,
         irrespective of any accounting treatment.

                  (iv) In the case of the issuance of options to purchase or
         rights to subscribe for Common Stock, securities by their terms
         convertible into or exchangeable for Common Stock, or options to
         purchase or rights to subscribe for such convertible or exchangeable
         securities:

<PAGE>   8

                           (a) the aggregate maximum number of shares of Common
                  Stock deliverable upon exercise of such options to purchase or
                  rights to subscribe for Common Stock shall be deemed to have
                  been issued at the time such options or rights were issued and
                  for a consideration equal to the consideration (determined in
                  the manner provided in subdivisions (ii) and (iii) above), if
                  any, received by the corporation upon the issuance of such
                  options or rights plus the minimum purchase price provided in
                  such options or rights for the Common Stock covered thereby;

                           (b) the aggregate maximum number of shares of Common
                  Stock deliverable upon conversion of or in exchange for any
                  such convertible or exchangeable securities or upon the
                  exercise of options to purchase or rights to subscribe for
                  such convertible or exchangeable securities and subsequent
                  conversion or exchange thereof shall be deemed to have been
                  issued at the time such securities, options, or rights were
                  issued and for a consideration equal to the consideration
                  received by the corporation for any such securities and
                  related options or rights (excluding any cash received on
                  account of accrued interest or accrued dividends), plus the
                  additional consideration, if any, to be received by the
                  corporation upon the conversion or exchange of such securities
                  or the exercise of any related options or rights (the
                  consideration in each case to be determined in the manner
                  provided in subdivisions (ii) and (iii) above);

                           (c) on any change in the number of shares or exercise
                  price of Common Stock deliverable upon exercise of any such
                  options or rights or conversions of or exchange for such
                  securities, other than a change resulting from the
                  antidilution provisions thereof, each Conversion Price
                  previously adjusted shall forthwith be readjusted to such
                  Conversion Price as would have been obtained had the
                  adjustment made upon the issuance of such options, rights or
                  securities not converted prior to such change or options or
                  rights related to such securities not converted prior to such
                  change been made upon the basis of such change; and

                           (d) on the expiration of any such options or rights,
                  the termination of any such rights to convert or exchange or
                  the expiration of any options or rights related to such
                  convertible or exchangeable securities, each Conversion Price
                  previously adjusted shall forthwith be readjusted to such
                  Conversion Price as would have obtained had the adjustment
                  made upon the issuance of such options, rights, securities or
                  options or rights related to such securities been made upon
                  the basis of the issuance of only the number of shares of
                  Common Stock actually issued upon the exercise of such options
                  or rights, upon the conversion or exchange of such securities,
                  or upon the exercise of the options or rights related to such
                  securities and subsequent conversion or exchange thereof.

<PAGE>   9

                  (v) "Excluded Stock" means (1) shares of Common Stock issued
         by the corporation as a stock dividend or upon any subdivision,
         split-up or combination of shares of Common Stock; (2) shares of Common
         Stock issued upon exercise of incentive or non-qualified stock options
         outstanding as of the date hereof; (3) shares of Common Stock issued
         upon exercise of incentive or non-qualified options granted after the
         date hereof to employees, consultants or non-employee directors
         pursuant to the existing stock option plans adopted by the Board; (4)
         shares of Common Stock issued by the corporation upon conversion of
         shares of Preferred Stock; (5) shares of Common Stock issued upon
         exercise of any warrants issued to ESA, Inc., a Massachusetts
         corporation, pursuant to the Warrant to Purchase Common Stock of
         Genomic Solutions Inc. dated October 13 1998, (6) shares of Common
         Stock issued upon exercise of any warrants issued pursuant to the terms
         of the Business Loan Agreement between the Company, White Pines Limited
         Partnership I and others dated April 23, 1999; (7) shares of Common
         Stock issued upon exercise of any warrants issued pursuant to the terms
         of the Business Loan Agreement between the Company, White Pines Limited
         Partnership I and others dated October 28, 1999, or (7) securities that
         are or were declared to be "Excluded Stock" for purposes of this
         Section by the holders of 66 2/3% of the outstanding shares of Series B
         Preferred Stock, Series C Preferred Stock, Series M Preferred Stock,
         Series D Preferred Stock and Series P Preferred Stock, as applicable,
         each voting as a separate class and only with respect to the shares
         held by such class.

                  (vi)     All  calculations  made pursuant to Sections 3.c. and
         3.d. shall be made to the nearest one hundredths (1/100) of one cent or
         the nearest one tenth (1/10) of a share, as the case may be.

                  (vii) In any case in which the provisions of Sections 3.c. and
         3.d. shall require that an adjustment shall become effective
         immediately after a record date of an event, the corporation may defer
         until the occurrence of such event (i) issuing to the holder of any
         share of Preferred Stock converted after such record date and before
         the occurrence of such event the shares of capital stock issuable upon
         such conversion by reason of the adjustment required by such event in
         addition to the shares of capital stock issuable upon such conversion
         before giving effect to such adjustments, and (ii) paying to such
         holder any amount in cash in lieu of a fractional share of capital
         stock pursuant to paragraph (d) above; provided, however, that the
         corporation shall deliver to such holder an appropriate instrument
         evidencing such holder's right to receive such additional shares and
         such cash.

         e. No Impairment. This corporation will not, by amendment of its
     Certificate of Incorporation or through any reorganization,
     recapitalization, transfer of assets, consolidation, merger, dissolution,
     issue or sale of securities or any other voluntary action, avoid or seek to
     avoid the observance or performance of any of the terms to be observed or
     performed hereunder by this corporation, but will at all times in good
     faith assist in the

<PAGE>   10

     carrying out of all the provisions of this Section 3 and in the taking of
     all such action as may be necessary or appropriate in order to protect the
     Conversion Rights of the holder of shares of the Series P Preferred Stock
     against impairment.

         f.       No Fractional Shares and Certificate as to Adjustments.

                  (i) No fractional shares shall be issued upon conversion of
         the Series P Preferred Stock. The number of shares of Common Stock to
         be issued to each holder of shares of Series P Preferred Stock upon
         conversion shall be computed on the basis of the aggregate number of
         shares of Series P Preferred Stock to be converted. Instead of any
         fractional shares of Common Stock which would otherwise be issuable
         upon conversion of any shares of Series P Preferred Stock, the
         corporation shall pay a cash adjustment in respect of such fractional
         interest in an amount equal to the product of (i) the price of one
         share of Common Stock as determined in good faith by the Board of
         Directors of the corporation and (ii) such fractional interest. The
         holders of fractional interests shall not be entitled to any rights as
         stockholders of the corporation in respect of such fractional
         interests.

                  (ii) Upon the corporation's awareness of an event that would
         cause an adjustment or readjustment of the Conversion Price of Series P
         Preferred Stock pursuant to this Section 3, this corporation, at its
         expense, shall promptly compute such adjustment or readjustment in
         accordance with the terms hereof and prepare and furnish to each holder
         of shares of Series P Preferred Stock a certificate setting forth such
         adjustment or readjustment and showing in detail the facts upon which
         such adjustment or readjustment is based. This corporation shall, upon
         the written request at any time of any holder of shares of Series P
         Preferred Stock, furnish or cause to be furnished to such holder a like
         certificate setting forth (A) such adjustment and readjustment, (B) the
         Conversion Price at the time in effect, and (C) a number of shares of
         Common Stock and the value, if any, of other property which at the time
         would be received upon the conversion of a share of Series P Preferred
         Stock.

         g.       Notices of Record Date. In the event of any taking by this
     corporation of a record of the holders of any class of securities for the
     purpose of determining the holders thereof who are entitled to receive any
     dividend (other than a cash dividend) or other distribution, any right to
     subscribe for, purchase or otherwise acquire any shares of stock of any
     class or any other securities or property, or to receive any other right,
     this corporation shall mail to each holder of shares of Series P Preferred
     Stock at least twenty (20) days prior to the date specified therein, a
     notice specifying the date on which any such record is to be taken for the
     purpose of such dividend, distribution or right, and the amount and
     character of such dividend, distribution or right.

         h.       Reservation of Stock Issuable Upon Conversion. This
     corporation shall at all times reserve and keep available out of its
     authorized but unissued shares of Common Stock solely for the purpose of
     effecting the conversion of shares of the Series P Preferred

<PAGE>   11

     Stock such number of its shares of Common Stock as shall from time to time
     be sufficient to effect the conversion of all outstanding shares of the
     Series P Preferred Stock; and if at any time the number of authorized but
     unissued shares of Common Stock shall not be sufficient to effect the
     conversion of all the outstanding shares of the Series P Preferred Stock in
     addition to such other remedies as shall be available to the holder of such
     shares of Preferred Stock, this corporation will take such corporate action
     as may, in the opinion of its counsel, be necessary to increase its
     authorized but unissued shares of Common Stock to such number of shares as
     shall be sufficient for such purposes.

         i. Notices. Any notice required by the provisions of this Section to be
     given to the holders of shares of Series P Preferred Stock shall be deemed
     given if deposited in the United States mail, postage prepaid, and
     addressed to each holder of record at his address appearing on the books of
     this corporation.

     4.  Voting.

     a.  Voting Rights of Series P Preferred Stock. The holder of each share
of Series P Preferred Stock shall have the right to one vote for each share of
Common Stock into which such Series P Preferred Stock could then be converted
(with any fractional shares, determined on an aggregate conversion basis, being
rounded to the nearest whole share), and with respect to such vote, such holder
shall have full voting rights and powers equal to the voting rights and powers
of holders of shares of Common Stock, and shall be entitled, notwithstanding any
provision hereof, to notice of any stockholders' meeting in accordance with the
bylaws of this corporation, and shall be entitled to vote (except as otherwise
expressly provided herein or as required by law), together with holders of
shares of Common Stock as a single class, with respect to any question upon
which holders of shares of Common Stock have the right to vote. Election of
directors need not be by written ballot, unless the bylaws of the corporation
shall so provide.

     b. Right to Vote on the Sale of the Corporation. The corporation shall
not effect a Sale of the Corporation, as defined in Section 2.c, without first
obtaining the written consent of (i) the holders of 66-2/3% of the shares of the
Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock
(all treated as if fully converted to common stock) and the common stock issued
upon conversion of the Series B, Series C and Series D Preferred Stock, all
voting together as a single class, and (ii) the holders of a majority of the
then outstanding shares of Series P Preferred Stock.

     5. Protective Provisions. Subject to the rights of series of Preferred
Stock which may from time to time come into existence, so long as shares of
Series P Preferred Stock are outstanding, this corporation shall not without
first obtaining the approval (by vote or written consent, as provided by law) of
holders of a majority of the then outstanding shares of Series P Preferred
Stock:

         a. amend, alter or change the Amended and Restated Certificate of
     Incorporation or the corporation's bylaws so as to (a) alter or change the
     rights, preferences or privileges of the shares of Series P Preferred Stock
     in a manner that

<PAGE>   12

     adversely affects the holders of shares of the Series P Preferred Stock,
     (b) prevent or impede the exercise by PerkinElmer of its Option (as defined
     in the Securities Purchase Agreements) under the Securities Purchase
     Agreements, or (c) prevent or impede PerkinElmer from controlling this
     corporation following the exercise of its Option for 100% of the securities
     subject to the Option.

         b. increase the authorized number of shares of Series P Preferred
     Stock, Series D Preferred Stock, Series C Preferred Stock or Series B
     Preferred Stock.

         c. declare any dividends on, or make any other distribution with
     respect to, any shares of its capital stock or apply any of its property or
     assets to the purchase, redemption or other retirement of any shares of any
     class of its capital stock, or set apart any sum for any such payments.

         d. issue any shares of Series P Preferred Stock.

     6.  Status of Converted Stock. If any shares of Series P Preferred Stock
shall be converted pursuant to Section 3, the shares so converted shall be
canceled and shall not be issuable by the corporation. The Amended and Restated
Certificate of Incorporation shall be appropriately amended to effect the
corresponding reduction in the corporation's authorized capital stock.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}]]